Copyright (c) Queen's Printer, Victoria, British Columbia, Canada |
Licence Disclaimer |
This archived statute consolidation is current to November 25, 1993 and includes changes enacted and in force by that date. |
1. In this Act
"advertise" means to promote, directly or indirectly, the sale or disposal of Schedule A drugs;
"board" means the board of examiners established under this Act;
"bylaws" means the bylaws of the college;
"clerkship" means the training given in a pharmacy by a pharmacist to a student or graduate;
"college" means the College of Pharmacists of British Columbia;
"committee" means the discipline committee;
"council" means the council of the college;
"dispense" includes the preparation and release of a drug prescribed in a prescription and the taking of steps to ensure the pharmaceutical and therapeutic suitability of a drug for its intended use;
"drug" means a substance or combination of substances used or intended to be used to diagnose, treat, mitigate or prevent a disease, disorder or abnormal physical or mental state, or a symptom of them, or to restore, correct or modify organic functions, in man or animal, and includes a substance or combination of substances named or included by reference in Schedule A or Schedule B;
"executive" means the executive committee of the council;
"facility" means a place, other than a pharmacy, from which Schedule A drugs are distributed;
"graduate" means a person registered under this Act as a graduate;
"inspector" means a person so appointed by the council;
"interchangeable drug" means a drug of equal quality that contains, in the same dosage form, the same amount of the same active ingredients as the drug prescribed;
"manager" means a pharmacist who is designated in a pharmacy licence as manager of a pharmacy;
"pharmacist" means a member of the college who is
(a) registered under this Act or its predecessor as a pharmacist; and
(b) except in sections 3, 15 and 48 (2) (c) the holder of a valid and subsisting licence issued by the college entitling him to practise as a pharmacist in the Province;
"pharmacy" means a place where drugs may be dispensed, stored or sold to the public;
"practitioner" means a person authorized under the law of any province to practise medicine, dentistry, podiatry or veterinary medicine;
"prescription" means a direction from a practitioner that a specified amount of a specified drug be dispensed;
"registrar" means the registrar of the college appointed by the council and includes a deputy registrar;
"respondent" means a person notified by citation under section 34;
"rules" means the rules of the college established by the council;
"Schedule A drug" means a drug named or included by reference in Schedule A;
"Schedule B drug" means a drug named or included by reference in Schedule B;
"sell" includes barter, distribute, supply, and offer, expose, advertise or possess for the purposes of selling;
"student" means a person so registered under this Act.
Historical Note(s): 1974-62-1; 1976-39-1; 1983-10-21, effective October 26, 1983 (B.C. Reg. 393/83).
2. The Pharmaceutical Association of the Province of British Columbia, incorporated under the Pharmacy Act, 1891, is continued as a corporation under the name "College of Pharmacists of British Columbia".
Historical Note(s): 1974-62-2; 1976-39-2.
3. Membership in the college consists of those persons who are or become pharmacists under this Act.
Historical Note(s): 1974-62-3.
4. (1) The college shall hold an annual general meeting of the members in each year.
(2) A special general meeting of the college may be called or, where the council receives a petition from not less than 75 pharmacists, shall be called, by the council.
(3) Annual and special general meetings shall be called by the council under the rules.
Historical Note(s): 1974-62-4.
5. (1) A person who is not a pharmacist shall not vote at a meeting of the college.
(2) Quorum at a meeting of the college is 25 pharmacists.
(3) A person shall not act as proxy at a meeting for more than 5 pharmacists.
(4) A majority of persons voting on a resolution or motion is required to pass it.
Historical Note(s): 1974-62-5.
6. The management, administration and control of the property, revenue, expenditure, business and affairs of the college are vested in the council; but the power to buy or sell land is vested in the college.
Historical Note(s): 1974-62-6.
7. The council shall consist of not less than 8 or more than 17 persons, of whom
(a) not less than 6 or more than 15 shall be pharmacists resident in the Province and elected to the council under section 8;
(b) one, who need not be a pharmacist, shall be appointed by the Lieutenant Governor in Council; and
(c) one shall be the person who is dean of the Faculty of Pharmaceutical Sciences at The University of British Columbia.
Historical Note(s): 1974-62-7.
8. For the purpose of electing the elected members of council, the college shall by bylaw,
(a) divide the Province into electoral districts;
(b) fix the number of pharmacists who are
(i) members of the council,
(ii) from each electoral district; and
(iii) entitled to vote in each electoral district; and
(c) fix the manner of holding, and of voting at, an election.
Historical Note(s): 1974-62-8.
9. A member of council holds office for a term of 2 years but ceases to be a member
(a) on resignation; or
(b) in the case of elected members, on ceasing to be a pharmacist, or on ceasing to practise as a pharmacist in the electoral district from which he was elected, or on suspension of his licence.
Historical Note(s): 1974-62-9.
10. Where a vacancy occurs in an elected member's position on the council, the council shall appoint another pharmacist from the electoral district from which the vacating member was elected. The appointee holds office for the remainder of the vacating member's term.
Historical Note(s): 1974-62-10.
11. (1) Quorum at a council meeting is 6 members unless the council fixes a higher number.
(2) A majority of persons voting on a resolution or motion is required to pass it.
(3) A resolution agreed to in writing by every member of the council has the same effect as if passed at a meeting of the council.
Historical Note(s): 1974-62-11.
12. (1) There shall be an executive committee of the council composed of
(a) the president of the college; and
(b) not less than 4 other council members appointed by the council at its first meeting after the college annual general meeting, to hold office until replaced by the council.
(2) Where a vacancy occurs in the executive, the president of the college may appoint an interim replacement from the members of the council to hold office until the council appoints a replacement.
(3) Subject to the control of the council, the executive has power to do any of the things vested in the council under section 6.
(4) Quorum at an executive meeting is 3/4 of its members.
(5) The executive shall present a report of its activities at each meeting of council.
Historical Note(s): 1974-62-12.
13. The council shall appoint a pharmacist as registrar to carry out the duties imposed by this Act, the bylaws and rules, and other duties the council determines.
Historical Note(s): 1974-62-13.
14. (1) The registrar shall maintain the following registers, each to contain the information required by the rules:
(a) a register of the members of the college;
(b) a register of pharmacists;
(c) a register of pharmacies;
(d) a register of graduates and students;
(e) a provisional register; and
(f) as many other registers as the council directs.
(2) An extract from a register, certified by the registrar, is proof in the absence of evidence to the contrary of the truth of its contents in any proceeding.
(3) If the council is satisfied that an entry has been fraudulently or incorrectly made, it may direct the registrar to amend a register.
Historical Note(s): 1974-62-14.
15. (1) A person may apply to the registrar, in the form and manner specified by the rules, to be registered with the college as a pharmacist who
(a) has graduated with a degree of bachelor of science in pharmacy from The University of British Columbia, or is registered with the Pharmacy Examining Board of Canada and has passed examinations set by the board;
(b) has served the period of clerkship specified by the bylaws;
(c) has paid the registration fee specified by the rules; and
(d) complies with this Act, the bylaws and rules.
(2) The registrar shall issue a diploma in the form specified by the rules to a person accepted for registration.
(3) The examination referred to in subsection (1) and any other examination required by this Act, the bylaws or rules, shall, where no other person is designated, be conducted by a board of examiners, the members of which shall be appointed on the recommendation of the college council by the Lieutenant Governor in Council. At least one member shall be a member of the Faculty of Pharmaceutical Sciences at The University of British Columbia.
Historical Note(s): 1974-62-15; 1982-72-14, proclaimed effective December 9, 1982; 1983-10-21, effective October 26, 1983 (B.C. Reg. 393/83).
16. A person who
(a) has graduated with a degree of bachelor of science in pharmacy, or equivalent, from a university outside the Province; or
(b) is enrolled as a student in a faculty of pharmacy at a university in Canada;
may, on payment of the fee specified by the rules and on satisfying the registrar of his educational standing, age, fluency in English and moral character, apply to the registrar to be registered with the college as a graduate where the person applies under paragraph (a) or as a student where the person applies under paragraph (b).
Historical Note(s): 1974-62-16; 1983-10-21, effective October 26, 1983 (B.C. Reg. 393/83).
17. (1) A person who is not a pharmacist, graduate or student registered under this Act, but who qualifies under section 16 (a), is a member of the Faculty of Pharmaceutical Sciences at The University of British Columbia and is approved by the executive, may, on payment of the fee specified by the rules, apply to be registered in the provisional register, subject to the terms the executive or council specifies.
(2) A person registered in the provisional register has the rights of a member of the college, other than election to the council, and is entitled to a certificate showing any terms specified.
Historical Note(s): 1974-62-17; 1983-10-21, effective October 26, 1983 (B.C. Reg. 393/83).
18. (1) A person shall not
(a) practise as a pharmacist;
(b) own a pharmacy;
(c) subject to section 51, dispense or sell a drug;
(d) act as agent for a pharmacist except in a pharmacy; or
(e) assume or use in any form, combination or manner the words "pharmaceutical, chemist, druggist, apothecary, pharmacist, pharmacy, medicines, drugs, drug store, drug department, drug sundries", or any other words of similar import that imply or are calculated to lead others to infer that he or it is licensed under this Act
unless he or it is a pharmacist, a facility or, where licensed under section 19, is a corporation in which a majority of directors are pharmacists, a hospital as defined in the Hospital Act, an association incorporated under the Cooperative Association Act or a society incorporated under the Society Act.
(2) The registrar shall not issue a licence to any person unless he is satisfied that the applicant complies with this Act, the bylaws and rules.
Historical Note(s): 1974-62-18; 1976-39-3.
19. (1) A person shall not operate a pharmacy unless the pharmacy is licensed under this section.
(2) An applicant for a pharmacy licence must apply to the registrar under the rules, pay the fee specified by the rules and satisfy the registrar that
(a) the pharmacy is to be under the bona fide management of a pharmacist; and
(b) the premises where the pharmacy is to be located are suitable for its operation.
(3) Where the registrar accepts an application he shall issue an annual licence in the name of the manager of the pharmacy for which the application was made. Where that manager ceases to manage the pharmacy, or where, subject to subsection (4), the ownership of the pharmacy changes, the licence expires.
(4) Where the owner of a pharmacy,
(a) becomes bankrupt, insolvent or makes an assignment for the general benefit of his creditors, the trustee in bankruptcy, liquidator or assignee may continue to operate the pharmacy for a period of not more than 6 months following the date of bankruptcy, insolvency or assignment, so long as the pharmacy is under the bona fide management of a pharmacist; or
(b) in the case of a sole proprietorship, dies, the personal representatives or trustees of his estate may, subject to any terms the council may impose, continue to operate the pharmacy for a period of not more than 5 years following the date of death so long as the pharmacy is under the bona fide management of a pharmacist.
(5) The manager shall notify the registrar of the names of every pharmacist, graduate or student employed in the pharmacy.
(6) A pharmacist who ceases to own, operate or manage a pharmacy shall immediately notify the registrar.
Historical Note(s): 1974-62-19; 1983-10-21, effective October 26, 1983 (B.C. Reg. 393/83).
20. A person authorized by any Act to prescribe drugs shall not, directly or indirectly, own a pharmacy.
Historical Note(s): 1974-62-20.
21. (1) Unless authorized by this Act, the bylaws or rules, a pharmacist shall not sell or dispose of a drug named or included by reference in Part 1 of Schedule A except
(a) on the prescription or order of a practitioner;
(b) to a pharmacist;
(c) by return to the manufacturer or wholesaler of the drug; or
(d) by destruction as authorized by the manager.
(2) The council may establish rules for the sale or disposal of a drug under subsection (1).
(3) Every pharmacist in a pharmacy is responsible for the protection from loss, theft or unlawful sale of all Schedule A drugs in the pharmacy.
Historical Note(s): 1974-62-21; 1976-39-4; 1983-10-21, effective October 26, 1983 (B.C. Reg. 393/83).
22. (1) Unless authorized by this Act, the bylaws or rules, a pharmacist shall not sell a drug named or included by reference in Part 2 of Schedule A except
(a) to another pharmacist or practitioner; or
(b) to a person who, along with the pharmacist, enters the sale in a poison register in the form in subsection (3), and, where the drug is repackaged by the pharmacist, he shall label the new package with the word "poison", the name, strength and quantity of the drug and the name and address of the pharmacy; and
(c) under the terms set out in Part 2.
(2) The poison register shall be open for inspection during normal business hours by the registrar, an inspector, a peace officer or at any time by any person acting under the authority of a court having jurisdiction in the matter.
(3) The poison register shall contain vertical columns for the date, the name and postal address of the purchaser, the name and quantity of poison sold, the purpose for which the poison is required and the signature of the purchaser and of the seller.
Historical Note(s): 1974-62-22,Sch. C.
23. Unless authorized by this Act, the bylaws or rules, a pharmacist shall not sell a drug named or included by reference in Part 3 of Schedule A except under the terms set out in that Part.
Historical Note(s): 1974-62-23; 1976-39-5.
24. Notwithstanding section 18, a Schedule B drug may be sold by any person under the terms set out in Schedule B.
Historical Note(s): 1974-62-24.
25. A person shall not make a misleading or untruthful statement or representation in connection with the sale or purchase of a Schedule A drug.
Historical Note(s): 1974-62-25.
26. The presence of a Schedule A drug in business premises is proof in the absence of evidence to the contrary that it is kept for sale.
Historical Note(s): 1974-62-26.
27. Subject to this Act, the bylaws and rules, a pharmacist named in a pharmacy licence as manager shall personally manage and be responsible for the operation of the pharmacy.
Historical Note(s): 1974-62-27.
28. (1) Except as specified by the rules, a pharmacy shall not be open for business unless a pharmacist is in the pharmacy.
(2) A graduate or student shall not sell or dispense a Schedule A drug unless he is directly supervised by a pharmacist.
(3) A pharmacist shall not, directly or indirectly, dispense or sell a drug except in a pharmacy, hospital or facility.
Historical Note(s): 1974-62-28,31(2); 1976-39-6; 1983-10-21, effective October 26, 1983 (B.C. Reg. 393/83).
29. (1) A pharmacist shall retain on file the original of a prescription dispensed by him and he shall, if requested to do so, provide a copy of the prescription to the person who presented it or to another pharmacist at his direction, unless the prescriber has indicated to the contrary.
(2) The copy of a prescription shall contain
(a) the name and address of the patient and of the prescriber;
(b) the name, strength, quantity and directions for use of the drug;
(c) the dates of the first and last filling of the prescription;
(d) the name and address of the pharmacy;
(e) the signature of the pharmacist supplying it; and
(f) an indication that it is a copy.
Historical Note(s): 1974-62-29.
30. Where a practitioner indicates on a prescription that a drug of a specified manufacturer or that no interchangeable drug is to be dispensed, a pharmacist shall not dispense an interchangeable drug. Otherwise a pharmacist may use an interchangeable drug where its price to the purchaser is no more than the price of the prescribed drug.
Historical Note(s): 1974-62-30.
31. A pharmacist shall display his diploma issued under section 15 in his place of employment in a position conspicuous to the public.
Historical Note(s): 1974-62-31(1).
32. (1) There shall be a committee of pharmacists to be known as the discipline committee, the members of which shall be appointed annually, or more often as need arises, by the council.
(2) The committee shall consist of a chairman who shall be appointed from among the members of council, and a minimum of 4 other pharmacists.
(3) Quorum of the committee is 3 unless fixed at a higher number by the council.
(4) Where a vacancy occurs in the committee, the remaining members, if their number is not less than 3, may appoint a council member as a replacement to serve until the council otherwise directs.
Historical Note(s): 1974-62-32.
33. The council may act as the discipline committee and while so acting it is subject, with the necessary changes and so far as they are applicable, to the provisions of this Act, the bylaws and rules relating to the committee.
Historical Note(s): 1974-62-33.
34. (1) The committee may make a preliminary investigation, and conduct a hearing into the conduct of a person registered under this Act.
(2) For a preliminary investigation an inspector authorized by the committee may inspect or seize records relating to the investigation. Anything seized shall be returned within 7 days after it was seized.
(3) For a hearing each member of the committee has the power and authority of a Commissioner under sections 12, 15 and 16 of the Inquiry Act.
(4) The committee shall notify by citation a person who is the subject of a hearing. The citation shall
(a) be in a form specified by the rules;
(b) be served on the person personally or by registered mail directed to his last address known to the registrar, not less than 2 weeks before the stated hearing date;
(c) include a statement of the nature and particulars of the conduct being investigated; and
(d) include a prominent warning that the committee may proceed to hear and decide the matter in the person's absence.
Historical Note(s): 1974-62-34; 1983-10-21, effective October 26, 1983 (B.C. Reg. 393/83).
35. The committee may suspend a respondent's licence and privileges under this Act until the conclusion of the hearing; and notice of the suspension shall be served on him personally, or by registered mail directed to his last address known to the registrar.
Historical Note(s): 1974-62-35.
36. A respondent may appear in person or by agent.
Historical Note(s): 1974-62-36.
37. The committee may, if satisfied that the respondent was served properly with notice of the hearing and no reasonable explanation is given for his absence, proceed with the hearing in his absence.
Historical Note(s): 1974-62-37.
38. The committee shall inform the respondent not later than one week following the hearing that he is exonerated of any wrongdoing, suffering from a physical or mental ailment that renders him, in the opinion of the committee, unfit to retain his licence and privileges under this Act, or guilty of
(a) misconduct, incompetence or negligence in the conduct of his profession;
(b) excessive personal use of alcohol or drugs to an extent that renders him, in the opinion of the committee, unfit to retain his licence and privileges under this Act; or
(c) a breach of duty imposed on him by this Act, the bylaws or rules, or by another Act of Canada or the Province relating to the sale or use of alcohol or drugs.
Historical Note(s): 1974-62-38.
39. The committee shall, not later than 2 weeks after the conclusion of the hearing, submit a summary of its findings of fact and, at its option, a recommendation of action to be taken, to the council.
Historical Note(s): 1974-62-39.
40. The committee may suspend a respondent's licence and privileges under this Act, or continue his suspension, until the council has acted under section 41. The suspension or continuation under this section shall not exceed 4 weeks.
Historical Note(s): 1974-62-40.
41. (1) Where the committee has not exonerated a respondent, the council may, not later than 4 weeks after the conclusion of the committee's hearing, on a resolution passed by 2/3 of its members voting on the resolution at a meeting,
(a) reprimand the respondent;
(b) impose conditions on the continued status of the respondent as a pharmacist, graduate or student;
(c) fine the respondent not less than $100 or more than $500 for a first offence and not less than $200 or more than $1,000 for a subsequent similar offence;
(d) suspend the respondent's licence and privileges for the time the council determines; and
(e) cancel the respondent's licence and strike his name from the register.
(2) Where the respondent notifies the council that he or his agent desires to make representations to the council respecting the penalty to be imposed, the council shall not entertain a resolution under subsection (1) until the respondent or his agent has had an opportunity to make representations. The council and the respondent, for this subsection, may agree to extend the 4 week limit referred to in subsection (1) and in section 40.
Historical Note(s): 1974-62-41.
42. Where the committee's decision under section 38 is unanimous, it may exercise the powers of the council under section 41 (1) (a), (b) and (c), and, with the consent of the respondent, under section 41 (1) (d) and (e).
Historical Note(s): 1974-62-42.
43. Subject to section 41 (2), where the council is satisfied that a person registered under this Act has been convicted by a court of an offence relating to his practice as a pharmacist, or of an indictable offence of any kind, the council may summarily take any action against that person that it is authorized to take against a respondent under section 41 (1).
Historical Note(s): 1974-62-43.
44. A respondent whose licence has been suspended or cancelled shall surrender his licence to the registrar, and shall not be employed or work in a pharmacy in any capacity.
Historical Note(s): 1974-62-44.
45. Except where a respondent is exonerated under section 38, the council or the committee may order him to pay the costs of the proceedings taken against him under this Act to be fixed by the council or the committee in an amount not exceeding $300 for each day or partial day of proceedings, together with disbursements.
Historical Note(s): 1974-62-45.
46. (1) An appeal may be taken by a respondent within one month to the Supreme Court from a decision of the council under section 41 or 43 suspending or cancelling his licence.
(2) The executive may, on terms it sees fit, including security for costs, stay the operation of any punishment or penalty imposed pending the outcome of the appeal.
(3) An appeal shall be brought by notice of intention to appeal filed in a registry of the court within the month. The appellant shall serve a copy of the notice on the registrar within the month.
(4) An appellant may, at his expense, obtain copies of any Notes or records that may have been made in any proceeding against him under this Act.
(5) The appellant shall give the registrar at least 7 clear days' notice of the place and time for the hearing.
(6) The council may appear and take part in the appeal.
(7) The court may give directions considered necessary to ensure the proper hearing of the appeal.
Historical Note(s): 1974-62-46.
47. Where a member of the College of Physicians and Surgeons of British Columbia has reason to suspect that a person registered under this Act is suffering from a physical or mental ailment or an excessive personal use of alcohol or drugs that might constitute a danger to the public, he shall immediately make a report to the registrar.
Historical Note(s): 1974-62-47.
48. (1) The council may make bylaws and rules.
(2) Without restricting subsection (1), the council may make bylaws respecting the
(a) qualification, training, examination and clerkship of graduates and students;
(b) continuing education of pharmacists and payment of fees for it;
(c) requirements for retraining a pharmacist prior to relicensing;
(d) standards of practice to be adhered to by a person registered under this Act, and in the operation of a pharmacy;
(e) accreditation of facilities and their drug safety standards;
(f) discipline of persons registered under this Act, and the conduct of disciplinary proceedings; and
(g) inclusion of additional drugs in, or the deletion of drugs from, or imposition of terms and conditions for drugs in, Schedules A and B.
(3) A bylaw does not come into force until approved by the Lieutenant Governor in Council.
(4) Without restricting subsection (1), the council may make rules respecting the
(a) conduct of meetings and elections;
(b) hiring and appointment of staff, including a registrar and inspectors, to conduct the business of the college, and to police the observance of this Act, the bylaws and rules;
(c) definition of staff duties and their remuneration;
(d) qualification, appointment and capacity of honorary members and members of the college who do not practise;
(e) form and content of registers under section 14, the diploma under section 15 and the citation under section 34;
(f) payment of expenses incurred by college members on college business;
(g) the scale and payment of fees, and the prescribing of forms;
(h) forms for registration under this Act, pharmacy and pharmacist licences, accredited institutions, persons to be registered in the provisional register, examinations and members not practising or retired;
(i) imposition of fines and suspension from practice for failure to pay fees; and
(j) affiliation of the college with another organization.
Historical Note(s): 1974-62-48; 1976-39-7.
49. In sections 49 to 55
"animal" means an animal, alive or dead, other than man, and includes all living organisms other than plants;
"medicated feed" means an animal feed that contains a veterinary drug;
"minister" includes a person designated in writing by the minister;
"veterinary drug" means a substance or combination of substances used or intended or represented to be used as a drug for or diagnosis of a disease of an animal, and includes a Schedule A drug;
"veterinary drug dispenser" means a person licensed under the regulations as a veterinary drug dispenser.
Historical Note(s): 1974-62-49; 1980-50-71, effective May 17, 1980.
50. A person, other than a pharmacist, or a veterinarian registered under the Veterinarians Act entitled to engage in private practice, shall not manufacture or sell a medicated feed or veterinary drug unless he has a valid and subsisting licence issued to him under section 51.
Historical Note(s): 1974-62-50.
51. (1) On application in the form and payment of the fee prescribed, the minister may issue, on terms he or the regulations may prescribe, a licence to the applicant enabling him to manufacture or sell medicated feed or veterinary drugs.
(2) Where the regulations require the presence of a veterinary drug dispenser on the premises of a licensee, the licensee shall inform the provincial veterinarian appointed under the Animal Disease Control Act of the name and certificate number of the veterinary drug dispenser.
(3) Where the minister determines that a person licensed under this section has contravened a term of his licence, the minister may cancel the licence; and for the purposes of this subsection the minister's decision is final and not subject to appeal.
Historical Note(s): 1974-62-51; 1988-31-13.
52. (1) The minister may, pursuant to the Public Service Act, appoint inspectors who may
(a) enter, during normal business hours, premises in which veterinary drugs are sold to ascertain whether this Act and the regulations are being complied with;
(b) examine and seize books and records relating to the use or sale of veterinary drugs;
(c) inspect an agricultural or horticultural crop, product, animal, animal product or animal feed and analyse it for the presence of a substance considered by the minister to be harmful to the health of a person or animal; and
(d) perform other duties imposed by the minister.
(2) The minister also may appoint special inspectors who shall have the powers and duties he determines.
Historical Note(s): 1974-62-52.
53. Where a thing analysed under section 52 (1) (c) contains a substance considered by the minister harmful to the health of a person or animal, the minister may cause the thing to be destroyed, or prohibit its sale or use for the time he considers necessary. He is not liable to pay compensation for an economic loss that may occur as a result of any action taken under this section.
Historical Note(s): 1974-62-53.
54. Notwithstanding anything in this Act or the regulations to the contrary, the minister may prohibit the use in the Province of any veterinary drug for veterinary purposes.
Historical Note(s): 1974-62-54.
55. For the purpose of sections 49 to 54, the Lieutenant Governor in Council may make regulations. Without restricting the foregoing he may make regulations respecting
(a) the issuing of licences and the fees for them under section 51;
(b) licence duration, renewal, cancellation, suspension, extent and production;
(c) the keeping and inspection of registers of licences and veterinary drug dispensers and the payment of fees;
(d) the qualification of applicants under section 51;
(e) the storage, transportation and sale of veterinary drugs;
(f) the analysis of a thing listed in section 52 (1) (c);
(g) a maximum residue content of a veterinary drug in a thing subject to analysis under section 52 (1) (c);
(h) the Schedule A drugs and their amounts that may be used either to impregnate feeding mashes to prevent, control or treat animal diseases, or to prevent, control or treat specific animal diseases;
(i) the training courses, training and licensing for veterinary drug dispensers;
(j) the presence of a veterinary drug dispenser where veterinary drugs or medicated feeds are sold; and
(k) an advisory committee on veterinary drugs, and its duties, with representatives from the Ministries of Agriculture and Food and Health, the college and The British Columbia Veterinary Medical Association.
Historical Note(s): 1974-62-55; 1977-75-1; 1980-29-12.
56. A person shall not sell anything representing it to be a drug or a particular drug where it is not a drug or the drug represented, as the case may be.
Historical Note(s): 1974-62-56.
57. A person shall not sell a drug after a date on which the drug is indicated or labelled to expire.
Historical Note(s): 1974-62-57.
58. A person who sells anything in contravention of this Act shall not be entitled to recover payment for the sale.
Historical Note(s): 1974-62-58.
59. Nothing in this Act, the bylaws or rules prevents
(a) a practitioner from directly supplying a drug to his patient;
(b) the manufacture or sale of a proprietary medicine defined by regulation under the Food and Drugs Act (Canada) that does not contain a Schedule A drug; or
(c) a wholesaler or manufacturer from selling a Schedule B drug to any person, a veterinary drug to a person licensed under section 51 or a Schedule A drug to a practitioner or pharmacist, another wholesaler or manufacturer or governments or universities for research and testing.
Historical Note(s): 1974-62-59(1); 1976-39-8.
60. Wholesalers and manufacturers of Schedule A drugs shall maintain a record of all sales of those drugs and allow an inspector under this Act to inspect the record at any time during normal business hours.
Historical Note(s): 1974-62-59(2).
61. (1) A person who contravenes this Act, the bylaws or rules commits an offence.
(2) The employer and manager of a person who contravenes this Act, the bylaws or rules is, whether or not the person is prosecuted for the offence, a party to and guilty of the offence. This subsection does not affect the liability of the person for the offence.
(3) Where a corporation commits an offence under this Act, the bylaws or rules, an officer, director, employee or agent of the corporation who directed, authorized, assented to, acquiesced or participated in the commission of the offence is, whether or not the corporation is prosecuted for the offence, a party to and guilty of the offence. This subsection does not affect the liability of the corporation for the offence.
Historical Note(s): 1974-62-60.
62. (1) Where the matter is in issue in a prosecution under section 61, the onus is on the defendant to prove that he is a licensed pharmacist or that he is the pharmacist named in the pharmacy licence.
(2) The production of a licence purporting to be issued under this Act is proof in the absence of evidence to the contrary of the truth of its contents.
Historical Note(s): 1974-62-62.
63. The onus is on the person to prove that an item is not a Schedule A drug where it is alleged that he has sold or disposed or attempted to sell or dispose of an item
(a) that purports to be a Schedule A drug;
(b) in a container marked to imply that it contains a Schedule A drug; or
(c) that the person has represented to be a Schedule A drug.
Historical Note(s): 1974-62-63.
64. Where evidence is introduced in a prosecution under this Act that a sign, title, advertisement or word has been published or used contrary to this Act, the bylaws or rules, the onus is on the defendant to prove that it was not published or used by him.
Historical Note(s): 1974-62-64.
65. (1) A certificate of an analyst appointed under the Food and Drugs Act (Canada) stating that he has analysed or examined a substance and stating the result of his analysis or examination is admissible in evidence in a proceeding under this Act, and is evidence of the statements contained in the certificate.
(2) The person against whom a certificate of analysis is admitted may, with leave of the court or chairman of the proceeding, require the attendance of the analyst for purposes of cross examination.
(3) Reasonable notice of an intention to introduce a certificate in evidence shall be given to the person against whom it is to be used, along with a copy of the certificate.
Historical Note(s): 1974-62-65.
66. The Lieutenant Governor in Council may, by order, exempt from any or all of the provisions of this Act, a
(a) health unit established under the Health Act;
(b) Provincial mental health facility under the Mental Health Act;
(c) community care facility holding a licence or interim permit under the Community Care Facility Act;
(d) Provincial tuberculosis institution under the Tuberculosis Institution Act; or
(e) place from which drugs are distributed under the Venereal Disease Act.
Historical Note(s): 1974-62-73.
Part 1
Drugs that may be sold by a pharmacist to a practitioner, or on the prescription of a practitioner ("F" or "G" indicates that the drug appears in Schedule F or G to the regulations of the Food and Drugs Act (Canada)):
F | ACEPROMAZINE and its salts. |
F | ACETANILIDE. |
F | ACETAZOLAMIDE. |
F | ACETOHEXAMIDE. |
F | ACETYLCARBROMAL. |
F | ACETYLCHOLINE CHLORIDE. |
F | ACONIAZIDE and its salts. |
F | ACTINOMYCIN D and its salts and derivatives. |
F | ACYCLOVIR and its salts. |
F | ADRENOCORTICAL HORMONES and their salts and derivatives (except hydrocortisone or hydrocortisone acetate, when sold as single medicinal ingredients in a concentration of 0.5% in preparations for topical use on the skin). |
F | ALFACALCIDOL. |
F | ALKYL NITRITES (including amyl nitrite and isobutyl nitrite). |
F | ALLOPURINOL. |
F | ALLYLISOPROPYLACETYLUREA. |
F | ALPHADOLONE and its salts. |
F | ALPHAXALONE. |
F | ALPRAZOLAM. |
F | ALTRENOGEST. |
F | ALTRETAMINE. |
F | AMANTADINE and its salts. |
F | AMBENONIUM CHLORIDE. |
F | AMIKACIN and its salts and derivatives. |
F | AMILORIDE and its salts. |
F | AMINOCAPROIC ACID. |
F | AMINOGLUTETHIMIDE. |
F | AMINOPHYLLINE. |
F | AMINOPYRINE and its derivatives. |
F | 4-AMINO-N-METHYLPTEROYL GLUTAMIC ACID and its salts. |
F | AMINOPTERIN and its salts. |
F | 4-AMINO-PTEROYL ASPartIC ACID and its salts. |
F | 4-AMINOSALICYLIC ACID and its salts. |
F | 5-AMINOSALICYLIC ACID. |
F | AMIODARONE and its salts. |
F | AMITRAZ. |
F | AMITRIPTYLINE and its salts. |
F | AMLODIPINE and its salts. |
F | AMMONIUM BROMIDE. |
F | AMOXAPINE. |
F | AMOXICILLIN. |
G | AMPHETAMINE and its salts. |
F | AMPHOTERICIN B and its salts and derivatives. |
F | AMPICILLIN and its salts and derivatives. |
F | AMPROLIUM and its salts. |
F | AMRINONE and its salts. |
F | AMSACRINE and its salts. |
F | ANTIPYRINE (except preparations for topical use.) |
F | APIOL, oil of. |
F | APOMORPHINE HYDROCHLORIDE. |
F | APRACLONIDINE and its salts. |
F | APRAMYCIN and its salts. |
F | APROTININ. |
F | ARSENIC and preparations and compounds thereof for human use. |
F | L-ASPARAGINASE. |
F | ATENOLOL and its salts. |
F | ATROPINE and its salts in ophthalmic or injectable preparations or internal preparations containing more than 0.125 mg per stated dose, or other preparations containing more than 0.1% by weight. |
F | AZACYCLONAL and its salts. |
F | AZARIBINE. |
F | AZATADINE and its salts. |
F | AZLOCILLIN and its salts and derivatives. |
F | BACLOFEN and its salts. |
G | BARBITURIC ACID and its salts and derivatives. |
F | BEMEGRIDE. |
F | BENACTYZINE and its salts. |
F | BENDAZAC and its salts. |
F | BENOXAPROFEN and its salts. |
F | BENSERAZIDE and its salts. |
F | BENZATHINE PENICILLIN and its salts and derivatives. |
F | BENZYDAMINE and its salts. |
F | BENZOYL PEROXIDE, in concentrations greater than 5% or when sold in combination with another medicinal ingredient. |
G | BENZPHETAMINE and its salts. |
F | BENZTROPINE and its salts. |
F | BETAHISTINE and its salts. |
F | BETAXOLOL and its salts. |
F | BETHANECHOL CHLORIDE. |
F | BETHANIDINE and its salts. |
F | BIPERIDEN and its salts. |
F | BIPERIDEN HYDROCHLORIDE. |
F | BISHYDROXYCOUMARIN and its salts and derivatives. |
F | BITOLTEROL and its salts. |
F | BLEOMYCIN. |
F | BOLDENONE UNDECYLENATE. |
F | BOTULINUM Toxin Type A. |
F | BRETYLIUM TOSYLATE. |
F | BROMAL and its derivatives: bromal hydrate, brometone, bromoform. |
F | BROMAZEPAM and its salts. |
F | BROMISOVAL. |
F | BROMOCRIPTINE and its salts. |
F | BUMETANIDE and its salts and derivatives. |
F | BUSERELIN and its salts. |
F | BUSPIRONE and its salts. |
F | BUSULFAN. |
F | BUTACAINE SULFATE, when sold or recommended for ophthalmic use. |
F | BUTOCONAZOLE and its salts. |
G | BUTORPHANOL and its salts. |
F | BUTAPERAZINE and its salts. |
F | CALCITONIN. |
F | CALCITRIOL. |
F | CALCIUM BROMIDE. |
F | CALCIUM BROMOLACTOBIONATE. |
F | CALCIUM CARBIMIDE. |
F | CANDICIDIN and its salts and derivatives. |
F | CANTHARIDES and its derivatives. |
F | CAPREOMYCIN and its salts and derivatives. |
F | CAPTODIAMINE and its salts. |
F | CAPTOPRIL and its salts. |
F | CARBACHOL. |
F | CARBAMAZEPINE. |
F | CARBAMYLCHOLINE. |
F | CARBENOXOLONE and its salts. |
F | CARBIDOPA and its salts. |
F | CARBIMAZOLE. |
F | CARBOCISTEINE. |
F | CARBOMYCIN and its salts and derivatives. |
F | CARBOPLATIN. |
F | CARBROMAL and its derivatives. |
F | CARISOPRODOL. |
F | CARMUSTINE. |
F | CARPHENAZINE and its salts. |
F | CEFONICID and its salts. |
F | CEFOPERAZONE and its salts and derivatives. |
F | CENTELLA ASIATICA EXTRACT and active principles thereof. |
F | CEPHALOSPORIN C and its salts and derivatives. |
F | CETIRIZINE and its salts. |
F | CHLORAL and its derivatives: chloral hydrate (except in preparations for external use containing not more than 1%), alpha-chloralose, butyl chloral hydrate, chloralformamide, chloralimide. |
F | CHLORAMBUCIL and its salts and derivatives. |
F | CHLORAMPHENICOL and its salts and derivatives. |
F | CHLORCYCLIZINE and its salts (except in preparations for external use only). |
F | CHLORDIAZEPOXIDE and its salts. |
F | CHLORHEXIDINE and its salts, when used as a tropical oral preparation. |
F | CHLORISONDAMINE and its salts. |
F | CHLORMEZANONE. |
F | CHLOROQUINE and its salts. |
F | CHLOROTHIAZIDE and its salts and derivatives. |
F | CHLORPHENOXAMINE HYDROCHLORIDE. |
G | CHLORPHENTERMINE and its salts. |
F | CHLORPROMAZINE and its salts. |
F | CHLORPROPAMIDE. |
F | CHLORPROTHIXENE and its salts. |
F | CHOLESTYRAMINE RESIN. |
F | CHOLINE SALICYLATE, when sold in combination with magnesium salicylate. |
F | CHOLINE THEOPHYLLINATE. |
F | CHYMOTRYPSIN. |
F | CICLOPIROX and its salts. |
F | CILASTATIN and its salts. |
F | CIMETIDINE and its salts. |
F | CINCHOPHEN and its salts. |
F | CINOXACIN. |
F | CIPROFLOXACIN and its salts. |
F | CISAPRIDE and its salts. |
F | CISPLATIN. |
F | CLENBUTEROL and its salts. |
F | CLODRONIC ACID and its salts. |
F | CLOFIBRATE. |
F | CLOMIPHENE and its salts. |
F | CLOMIPRAMINE and its salts. |
F | CLONAZEPAM and its salts. |
F | CLONIDINE and its salts. |
F | CLOPROSTENOL and its salts and derivatives. |
F | CLORAZEPIC ACID and its salts. |
F | CLOTRIMAZOLE and its salts. |
F | CLOXACILLIN and its salts and derivatives. |
F | COLCHICINE. |
F | COLESTIPOL and its salts. |
F | COLISTIN and its salts and derivatives. |
F | COLLAGENASE, when sold or recommended as a debriding agent. |
F | CORTICOTROPIN (ACTH). |
F | CROMOGLYCIC ACID and its salts. |
F | CYCLIZINE. |
F | CYCLOBENZAPRINE and its salts. |
F | CYCLOPENTOLATE and its salts in preparations for parenteral or opthalmic use, except when sold for use in diagnostic procedures to an optometrist registered in a province of Canada. |
F | CYCLOPHOSPHAMIDE. |
F | CYCLOSERINE. |
F | CYCLOSERINE. |
F | CYCLOSPORINE. |
F | CYPROTERONE ACETATE. |
F | CYTARABINE and its salts. |
F | DACARBAZINE. |
F | DACTINOMYCIN. |
F | DANAZOL. |
F | DANTROLENE and its salts. |
F | DAPIPRAZOLE and its salts. |
F | DAUNORUBICINE and its salts. |
F | DEANOL and its salts and derivatives. |
F | DEBRISOQUIN and its salts. |
F | DEFEROXAMINE and its salts. |
F | DEHYDROCHOLIC ACID, its salts and preparations. |
F | DESERPIDINE. |
F | DESIPRAMINE and its salts. |
F | DESMOPRESSIN and its salts. |
F | DETOMIDINE and its salts. |
F | DIAMINODIPHENYLSULFONE and its analogues and derivatives. |
F | DIAZEPAM and its salts. |
F | DIAZOXIDE and its salts. |
F | DICHLOROACETIC ACID. |
F | DICHLORPHENAMIDE. |
F | DICLOFENAC and its salts. |
F | DICLOXACILLIN and its salts and derivatives. |
F | DIDANOSINE and its salts and derivatives. |
F | DIETHYLBROMACETAMIDE. |
F | DIETHYLCARBAMAZINE and its salts. |
G | DIETHYLPROPION and its salts. |
F | DIETHYLSTILBESTROL and its salts and derivatives. |
F | DIFLUNISAL and its salts. |
F | DIGITALIS LANATA and its glycosides. |
F | DIGITALIS PURPUREA and its glycosides. |
F | DIGOXIN IMMUNE FAB (ovine). |
F | DIHYDROSTREPTMYCIN and its salts and derivatives (except when sold for veterinary purposes in conformity with requirements listed below). |
F | DIHYDROTACHYSTEROL. |
F | DIIODOHYDROXYQUIN (except in preparations for topical use on the skin). |
F | DILTIAZEM and its salts. |
F | DIMERCAPROL. |
F | DIMETHYLSULFOXIDE. |
F | 2,4-DINITROPHENOL and its salts and derivatives. |
F | DINOPROSTONE and its salts and derivatives. |
F | DIPHENIDOL and its salts. |
F | DIPHENYLHYDANTOIN (phenytoin) and its salts. |
F | DIPIVEFRIN and its salts. |
F | DIPROPHYLLINE and its salts. |
F | DIPYRIDAMOLE. |
F | DISULFIRAM. |
F | DISOPYRAMIDE and its salts. |
F | DITHRANOL (anthralin) over 0.5%. |
F | DOBUTAMINE and its salts. |
F | DOMPERIDONE. |
F | DOPAMINE and its salts. |
F | DOXACURIUM CHLORIDE. |
F | DOXAPRAM. |
F | DOXEPIN and its salts. |
F | DOXORUBICIN and its salts. |
F | DOXYCYCLINE. |
F | DOXYLAMINE and it salts, when sold or recommended for use in the nausea and vomiting of pregnancy. |
F | DROPERIDOL and its salts. |
F | ECONAZOLE and its salts. |
F | ECOTHIOPHATE and its salts. |
F | ECTYLUREA and its salts. |
F | EDROPHONIUM CHLORIDE. |
F | EMBUTRAMIDE. |
F | EMYLCAMATE. |
F | ENALAPRILAT and its salts and derivatives. |
F | ENFLURANE. |
F | ENROFLOXACIN. |
F | EPHEDRINE and its salts for internal use containing ephedrine as the single active ingredient. |
F | EPINEPHRINE when sold for ophthalmic use or as an aerosol bronchodilator. |
F | EPIRUBICINE and its salts. |
F | EPSIRANTEL. |
F | ERGOT ALKALOIDS and their salts. |
F | ERYTHRITYL TETRANITRATE. |
F | ERYTHROMYCIN and its salts and derivatives (except when sold for veterinary purposes in conformity with the requirements listed below or except as provided for in Schedule B). |
F | ERYTHROPOIETIN. |
F | ESMOLOL and its salts. |
F | ESTRAMUSTINE and its salts. |
F | ETHACRYNIC ACID. |
F | ETHAMBUTOL and its salts. |
F | ETHANOLAMINE OLEATE. |
F | ETHINAMATE. |
F | ETHIONAMIDE and its salts. |
F | ETHOMOXANE and its salts. |
F | ETHOPROPAZINE and its salts. |
F | ETHOTOIN and its salts. |
F | ETHYL TRICHLORAMATE. |
F | ETIDRONIC ACID and its salts. |
F | ETOPOSIDE. |
F | ETRETINATE. |
F | ETRYPTAMINE and its salts. |
F | ETYMEMAZINE and its salts. |
F | FAMOTIDINE and its salts. |
F | FELODIPINE and its salts. |
F | FENFLURAMINE and its salts. |
F | FENOFIBRATE. |
F | FENOPROFEN and its salts. |
F | FENoteROL and its salts. |
F | FIBRINOLYSIN, when sold or recommended as a debriding agent. |
F | FILGRASTIM. |
F | FLAVOXATE and its salts. |
F | FLECAINIDE and its salts. |
F | FLOCTAFENINE. |
F | FLORANTYRONE. |
F | FLUCONAZOLE. |
F | FLUCYTOSINE. |
F | FLUDARABINE and its salts and derivatives. |
F | FLUNARIZINE and its salts. |
F | FLUNIXIN and its salts and derivatives. |
F | FLUOROURACIL and its derivatives. |
F | FLUOXETINE and its salts. |
F | FLUPENTIXOL and its salts and derivatives. |
F | FLUPHENAZINE and its salts. |
F | FLUPROSTENOL and its salts and derivatives. |
F | FLURAZEPAM and its salts. |
F | FLURBIPROFEN and its salts. |
F | FLUSPIRILENE. |
F | FLUTAMIDE. |
F | FOLIC ACID in recommended daily dosage of more than 1.0 mg. |
F | FOSINOPRIL and its salts. |
F | FRAMYCETIN and its salts and derivatives. |
F | FURALTADONE and its salts. |
F | FURAZOLIDONE and its salts (except as provided for in Schedule B). |
F | FUROSEMIDE. |
F | FUSIDIC ACID and its salts. |
F | GALLAMINE TRIETHIODIDE. |
F | GALLIUM and its salts. |
F | GANCICLOVIR and its salts. |
F | GEMFIBROZIL and its salts. |
F | GENTAMICIN and its salts and derivatives. |
F | GLICLAZIDE. |
F | GLIPIZIDE. |
F | GLUTETHIMIDE. |
F | GLYBURIDE and its salts and derivatives. |
F | GOLD and its salts and the following derivatives: auranofin, aurothioglucose, sodium aurothiomalate. |
F | GONADORELIN and its salts. |
F | GOSERELIN and its salts. |
F | GRISEOFULVIN and its salts and derivatives. |
F | GUANETHIDINE and its salts. |
F | HALAZEPAM and its salts. |
F | HALOPERIDOL. |
F | HALOTHANE. |
F | HEPARIN and its salts (except for topical use). |
F | HETACILLIN and its salts and derivatives. |
F | HEXACHLOROPHENE and its salts over 0.75 per cent. |
F | HEXACYCLONATE SODIUM. |
F | HEXAMETHONIUM and its salts. |
F | HYALURONIC ACID and its salts, when sold or recommended for administration by intra-aticular injection to horses. |
F | HYDRALAZINE and its salts. |
F | HYDROXYCHLOROQUINE and its salts. |
F | 4-HYDROXY-COUMARIN and its derivatives when, sold or recommended as anticoagulants. |
F | HYOSCINE (Scopolamine) and its salts (except as provided for in Schedule A, Part 3, Division 2). |
F | HYOSCYAMINE and its salts, in preparations for internal use containing more than 0.065 mg per stated dose, or in preparations for external use containing more than 0.125%. |
F | HYDROXYUREA. |
F | HYDROXYZINE and its salts. |
F | IBUPROFEN and its salts, when sold in strengths greater than 200 mg per dosage form or when sold in combination with another medicinal ingredient. |
F | IDOXURIDINE. |
F | IFOSFAMIDE. |
F | IMIPENEM. |
F | IMIPRAMINE and its salts. |
F | INDAPAMIDE and its salts. |
F | INDOMETHACIN. |
F | INOSIPLEX. |
F | INTERFERON. |
F | IODOCHLORHYDROXYQUIN (except in preparations for topical use on the skin). |
F | IPRATROPIUM and its salts. |
F | IPRONIAZID and its salts. |
F | IRON derivatives for parenteral use only. |
F | ISOCARBOXAZID and its salts. |
F | ISOFLURANE. |
F | ISONIAZID. |
F | ISOPROPAMIDE and its salts. |
F | ISOPROTERENOL and its salts (Isoprenaline). |
F | ISOSORBIDE DINITRATE. |
F | ISOTRETINOIN and its salts. |
F | ISOXSUPRINE and its salts. |
F | IVERMECTIN, when sold or recommended for intramuscular administration to horses or for use in dogs. |
F | KANAMYCIN and its salts and derivatives. |
F | KETAMINE and its salts. |
F | KETAZOLAM and its salts. |
F | KETOCONAZOLE and its salts. |
F | KETOPROFEN and its salts. |
F | KETOROLAC and its salts. |
F | KETOTIFEN and its salts. |
F | LABETALOL and its salts. |
F | LACTIC ACID, when recommended for use by injection as a tissue sclerosing agent. |
F | LEUCOVORIN and its salts. |
F | LEUPROLIDE and its salts. |
F | LEVOBUNOLOL and its salts. |
F | LEVOCABASTINE and its salts and derivatives. |
F | LEVODOPA and its salts. |
F | LINCOMYCIN and its salts and derivatives. |
F | LIOTHYRONINE and its salts. |
F | LISINOPRIL and its salts and derivatives. |
F | LITHIUM and its salts. |
F | LOMUSTINE. |
F | LORAZEPAM and its salts. |
F | LOVASTATIN. |
F | LOXAPINE and its salts. |
F | MAGNESIUM GLUTAMATE HYDROBROMIDE. |
F | MAPROTILINE and its salts. |
F | MAZINDOL and its salts. |
F | MEBENDAZOLE (except when sold for veterinary purposes in conformity with the requirements listed below). |
F | MECAMYLAMINE and its salts. |
F | MECHLORETHAMINE and its salts. |
F | MECILLINAM and its salts and derivatives. |
F | MECLIZINE and its salts. |
F | MECLOFENAMIC ACID and its salts. |
F | MEFENAMIC ACID and its salts. |
F | MEGESTROL and its salts. |
F | MELPHALAN. |
F | MENOTROPINS (human post menopausal urinary gonadotrophins). |
F | MEPACRINE and its salts. |
F | MEPAZINE and its salts. |
F | MEPHENOXALONE. |
F | MEPHENTERMINE and its salts. |
F | MEPROBAMATE. |
F | MERCAPTOPURINE. |
F | MESNA. |
F | MESORIDAZINE and its salts. |
F | METALDEHYDE. |
F | METAXALONE. |
F | METFORMIN and its salts and derivatives. |
G | METHAMPHETAMINE and its salts. |
G | METHAQUALONE and its salts. |
F | METHENAMINE and its salts, when intended for oral use. |
F | METHICILLIN and its salts and derivatives. |
F | METHIMAZOLE. |
F | METHISAZONE. |
F | METHOIN (Mephenytoin) and its salts. |
F | METHOTREXATE and its salts. |
F | METHOTRIMEPRAZINE and its salts. |
F | METHOXAMINE and its salts. |
F | METHOXSALEN. |
F | METHYLDOPA and its salts. |
F | METHYLPARAFYNOL. |
G | METHYLPHENIDATE and its salts. |
F | METHYPRYLON. |
F | METHYSERGIDE and its salts and derivatives. |
F | METOCLOPRAMIDE. |
F | METOLAZONE and its salts. |
F | METOMIDATE and its salts. |
F | METOPIMAZINE and its salts. |
F | METOPROLOL and its salts. |
F | METRONIDAZOLE. |
F | METYRAPONE and its salts. |
F | MEXILETINE and its salts. |
F | MEZLOCILLIN and its salts and derivatives. |
F | MIBOLERONE. |
F | MICONAZOLE and its salts. |
F | MIDAZOLAM and its salts. |
F | MILBEMYCIN and its derivatives. |
F | MILRINONE and its salts. |
F | MINOXIDIL. |
F | MITOMYCIN and its salts. |
F | MITOTANE. |
F | MITOXANTRONE and its salts. |
F | NADOLOL and its salts. |
F | NAFARELIN and its salts and derivatives. |
F | NAFCILLIN and its salts and derivatives. |
F | NALIDIXIC ACID. |
F | NALOXONE and its salts. |
F | NANDROLONE and its derivatives. |
F | NAPROXEN and its salts. |
F | NARCOTICS (as defined in the Narcotic Control Act (Canada), including preparations containing narcotics listed in the schedule to the Narcotic Control Act but excluding those narcotic preparations referred to in section 36 of the regulations to the Narcotic Control Act). |
F | NEDOCROMIL and its salts. |
F | NEOCINCHOPHEN and its salts. |
F | NEOCINCOPHEN and its salts. |
F | NEOMYCIN and its salts and derivatives (except when sold as provided for in the third division of Schedule B). |
F | NEOSTIGMINE SALTS. |
F | NETILMICIN and its salts and derivatives. |
F | NIALAMIDE and its salts. |
F | NICARBAZIN. |
F | NICARDIPINE and its salts. |
F | NICOTINE and its salts, except in natural substances or when sold in a dosage form containing not more than the equivalent of 2 mg of nicotine. |
F | NIFEDIPINE. |
F | NILUTAMIDE. |
F | NIMODIPINE and its salts. |
F | NITRAZEPAM and it salts. |
F | NITROFURANTOIN and its salts (except when sold for veterinary purposes in conformity with the requirements listed below). |
F | NIZATIDINE and its salts. |
F | NOMIFENSINE and its salts. |
F | NORFLOXACIN. |
F | NORTRYPTYLINE and its salts. |
F | NOVOBIOCIN and its salts and derivatives. |
G | NULBUPHINE and its salts. |
F | NYLIDRIN and its salts. |
F | NYSTATIN and its salts and derivatives (except preparations for topical use on the skin). |
F | OCTATROPINE METHYLBROMIDE. |
F | OCTREOTIDE. |
F | OLEANDOMYCIN and its salts and derivatives. |
F | OLSALAZINE and its salts. |
F | OMEPRAZOLE. |
F | ORCIPRENALINE (Metoproterenol) and its salts. |
F | ORMETOPRIM and its salts. |
F | ORNIDAZOLE. |
F | OXACILLIN and its salts and derivatives. |
F | OXANAMIDE. |
F | OXAPROZIN and its salts and derivatives. |
F | OXAZEPAM and its salts. |
F | OXOLINIC ACID and its salts. |
F | OXPRENOLOL and its salts. |
F | OXYBUTYNIN and its salts. |
F | OXYPHENBUTAZONE and its salts. |
F | OXYTOCIN. |
F | PAMIDRONIC ACID and its salts. |
F | PANCURONIUM and its salts. |
F | PAPAIN, when sold or recommended as a debriding agent. |
F | PAPAVERINE. |
F | PARA-AMINOSALICYLIC ACID and its salts and derivatives. |
F | PARALDEHYDE. |
F | PARAMETHADIONE. |
F | PARGYLINE and its salts. |
F | PARAMOMYCIN. |
F | PEMOLINE and its salts. |
F | PENICILLAMINE. |
F | PENICILLIN and its salts and derivatives (except when sold for veterinary purposes in conformity with requirements listed below). |
F | PENTAERYTHRITOL TETRANITRATE. |
F | PENTAMIDINE and its salts. |
F | PENTOLINIUM TARTRATE. |
F | PENTOXIFYLLINE and its salts. |
F | PERICYAZINE and its salts. |
F | PERPHENAZINE and its salts. |
F | PHACETOPERANE and its salts. |
F | PHENACEMIDE. |
F | PHENACETIN. |
F | PHENAGLYCODOL. |
F | PHENAZOPYRIDINE and its salts. |
G | PHENDIMETRAZINE and its salts. |
F | PHENELZINE and its salts. |
F | PHENFORMIN and its salts. |
F | PHENIPRAZINE and its salts. |
G | PHENMETRAZINE and its salts. |
G | PHENTERMINE and its salts. |
F | PHENTHOXATE and its salts. |
F | PHENTOLAMINE and its salts. |
F | PHENYLBUTAZONE and its salts. |
F | PHENYLEPHRINE and its salts in preparations for ophthalmic or parenteral use in concentrations greater than 2.5%. |
F | PHENYLINDANEDIONE and its derivatives. |
F | PHYSOSTIGMINE SALICYLATE. |
F | PILOCARPINE and its salts in preparations for ophthalmic use. |
F | PIMOZIDE. |
F | PINDOLOL and its salts. |
F | PIPAMAZINE. |
F | PIPERACETAZINE and its salts. |
F | PIPERILATE and its salts. |
F | PIPOBROMAN. |
F | PIPOTIAZINE and its salts. |
F | PIPRADROL and its salts. |
F | PIRENZEPINE and its salts. |
F | PIROXICAM and its salts. |
F | PIZOTYLINE and its salts. |
F | PODOPHYLLUM RESIN. |
F | POLYMIXIN B and its salts and derivatives (except for topical use or for local action in the oral cavity or nasal passages). |
F | POLYSULFATED GLYCOSAMINOGLYCAN. |
F | POTASSIUM BROMIDE. |
F | POTASSIUM PARA-AMINOBENZOATE (except in preparations for topical use on the skin). |
F | PRALIDOXIME and its salts. |
F | PRAVASTATIN and its salts. |
F | PRAZEPAM and its salts. |
F | PRAZOSIN and its salts. |
F | PRENYLAMINE and its salts. |
F | PRIMAQUINE and its salts. |
F | PRIMIDONE. |
F | PROBENECID and its salts. |
F | PROBUCOL. |
F | PROCAINAMIDE and its salts. |
F | PROCARBAZINE and its salts. |
F | PROCATEROL and its salts. |
F | PROCHLORPERAZINE and its salts. |
F | PROCYCLIDINE and its salts. |
F | PRODILIDINE and its salts. |
F | PROFENAMINE and its salts. |
F | PROGUANIL and its salts. |
F | PROMAZINE and its salts. |
F | PROPAFENONE and its salts. |
F | PROPARACAINE (except when sold for diagnostic purposes, to an optometrist registered with the British Columbia Optometric Association). |
F | PROPRANOLOL and its salts. |
F | PROSTAGLANDINS and their salts and derivatives. |
F | PROTHIPENDYL HYDROCHLORIDE. |
F | PROTIRELIN. |
F | PROTRIPTYLINE and its salts. |
F | PYRAZINAMIDE. |
F | PYRIDOSTIGMINE BROMIDE. |
F | PYRIMETHAMINE and its salts. |
F | QUINAPRIL and its salts and derivatives. |
F | QUINIDINE. |
F | RANITIDINE and its salts. |
F | RAUBASINE. |
F | RAUWOLFIA and its alkaloids and their salts. |
F | RESCINNAMINE. |
F | RESERPINE and its salts. |
F | RIBAVIRIN. |
F | RIFAMPIN and its salts and derivatives. |
F | RISTOCETIN. |
F | RITODRINE and its salts. |
F | RONIDAZOLE and its salts and derivatives. |
F | ROSOXACIN and its salts. |
F | SALBUTAMOL and its salts. |
F | SARALASIN and its salts. |
F | SELEGILINE and its salts. |
F | SERTRALINE and its salts. |
F | SEX HORMONES. |
F | SIMVASTATIN. |
F | SODIUM BROMIDE. |
F | SODIUM FLUORIDE (in solid oral dosage forms containing more than one milligram of fluoride ion). |
F | SODIUM NITROPRUSSIDE and its salts. |
F | SODIUM POLYSTYRENE SULFATE. |
F | SODIUM TETRADECYL SULFATE. |
F | SOMATREM. |
F | SOMATROPIN. |
F | SOMATROPIN (Human Growth Hormone). |
F | SOTALOL and its salts. |
F | SPECTINOMYCIN and its salts and derivatives. |
F | SPIRAMYCIN and its salts and derivatives. |
F | STANOZOLOL. |
F | STREPTOKINASE-STREPTODORNASE. |
F | STREPTOMYCIN and its salts and derivatives (except when sold for veterinary purposes in conformity with requirements listed below or except as provided for in Schedule B). |
F | STREPTOZOCIN. |
F | STRONTIUM BROMIDE. |
F | SUCCINIMIDE and its salts and derivatives (except those compounds used for decontaminating water). |
F | SUCRALFATE. |
F | SULCONAZOLE and its salts. |
F | SULFINPYRAZONE and its salts. |
F | SULFOXONE and its salts. |
F | SULINDAC and its salts. |
F | SULPHONAMIDES and their salts and derivatives (except when sold for veterinary purposes in conformity with requirements listed below or except as provided for in Schedule B). |
F | SULPHONES and their derivatives (including dapsone). |
F | SUMATRIPTAN and its salts. |
F | SUTILAINS, when sold or recommended as a debriding agent. |
F | SUXAMETHONIUM CHLORIDE. |
F | TAMOXIFEN and its salts. |
F | TEMAZEPAM and its salts. |
F | TENIPOSIDE. |
F | TERAZOSIN and its salts. |
F | TERBUTALINE and its salts. |
F | TERCONAZOLE and its salts. |
F | TETRACAINE HYDROCHLORIDE. |
F | TETRACYCLINE and its salts and derivatives (except when sold for veterinary purposes in conformity with requirements listed below or except as provided for in Schedule B). |
F | THALIDOMIDE. |
F | THEOBROMINE and its salts. |
F | THEOPHYLLINE and its salts. |
F | THIABENADAZOLE (except when sold for veterinary purposes in conformity with the requirements listed below). |
F | THIETHYLPERAZINE and its salts. |
G | THIOBARBITURIC ACID and its salts and derivatives. |
F | THIOCARLIDE. |
F | THIOGUANINE. |
F | THIOPROPAZATE and its salts. |
F | THIOPROPERAZINE and its salts. |
F | THIORIDAZINE and its salts. |
F | THIOTEPA. |
F | THIOTHIXENE and its salts. |
F | THIOURACIL and its derivatives. |
F | THYROID. |
F | THYROXIN and its salts. |
F | TIAPROFENIC ACID and its salts. |
F | TICARCILLIN and its salts and derivatives. |
F | TILMICOSIN. |
F | TIMOLOL and its salts. |
F | TINADAZOLE. |
F | TIOCONAZOLE and its salts. |
F | TOBRAMYCIN, its salts and derivatives. |
F | TOCAINIDE and its salts. |
F | TOLAZAMIDE. |
F | TOLAZOLINE and its salts. |
F | TOLBUTAMIDE. |
F | TOLMETIN and its salts. |
F | TRANEXAMIC ACID. |
F | TRANYLCYPROMINE. |
F | TRAZODONE and its salts. |
F | TREOSULFAN. |
F | TRETAMINE. |
F | TRETINOIN (Vitamin A acid). |
F | TRIAMTERINE and its salts. |
F | TRIAZOLAM and its salts. |
F | TRIFLUOPERAZINE and its salts. |
F | TRIFLUPROMAZINE and its salts. |
F | TRIFLURIDINE. |
F | TRIHEXYPHENIDYL and its salts. |
F | TRIIODOTHYROPROPIONIC ACID. |
F | TRILOSTANE. |
F | TRIMEBUTINE and its salts. |
F | TRIMEPRAZINE and its salts. |
F | TRIMETHADIONE. |
F | TRIMETHAPHAN CAMSYLATE. |
F | TRIMETHOPRIM and its salts. |
F | TRIMIPRAMINE and its salts. |
F | TRIOXSALEN. |
F | TROPICAMIDE and its salts in preparations for parenteral or ophthalmic use, except when sold for use in diagnostic procedures to an optometrist registered in a province of Canada. |
F | TRYPSIN, when sold or recommended as a debriding agent. |
F | L-TRYPTOPHAN, when sold as a single ingredient. |
F | TUBOCURARINE CHLORIDE. |
F | TYBAMATE. |
F | TYLOSINE and its salts and derivatives. |
F | URACIL MUSTARD and its salts. |
F | URSODEOXYCHOLIC ACID and its salts. |
F | VACCINES, the following: Brucellosis; Equine Influenza; Leptospirosis; Mink Plasmacytosis; Rabies. |
F | VALPROIC ACID and its salts. |
F | VANCOMYCIN and its salts and derivatives. |
F | VASOPRESSIN. |
F | VECURONIUM BROMIDE. |
F | VERAPAMIL and its salts. |
F | VERATRUM ALBUM and its alkaloids and their salts. |
F | VERATRUM VIRIDE and its alkaloids and their salts. |
F | VIDARABINE. |
F | VINBLASTINE and its salts. |
F | VINCRISTINE and its salts. |
F | VINDESINE and its salts. |
F | VIOMYCIN and its salts and derivatives. |
F | VIRGINIAMYCIN and its salts and derivatives. |
F | VITAMIN A in recommended daily dosage of more than 10,000 I.U. |
F | VITAMIN B12 with intrinsic factor concentrate. |
F | VITAMIN D in recommended daily dosage of more than 1,000 I.U. |
F | VITAMIN K. |
F | XANTHINOL NICOTINATE. |
F | XYLAZINE and its salts. |
F | YOHIMBINE and its salts. |
F | ZALCITABINE and its salts. |
F | ZIDOVUDINE. |
F | ZOMEPIRAC and its salts. |
Exemptions, for Veterinary Purposes
The following drugs, their salts and derivatives, may be sold by a pharmacist for veterinary purposes, provided that the drugs are stored in an area to which there is no public access, and provided that the drugs are clearly labelled as required by Bylaw B-19 (11) or if the original container is clearly labelled as "For Veterinary Use Only" and a record is kept of:
(a) date of sale;
(b) name, address and signature of purchaser;
(c) name and quantity of drug sold;
(d) kind of animal and purpose for which drug is required;
(e) signature of pharmacist (seller):
Dihydrostreptomycin.
Erythromycin.
Mebendazole.
Nitrofurantoin.
Penicillin (except amoxicillin, ampicillin, azlocillin, benzathine penicillin, carbenicillin, cloxacillin, dicloxacillin, hetacillin, mecillinam, methicillin, mezlocillin, nafcillin, oxacillin, and ticarcillin, their salts and derivatives).
Streptomycin.
Sulfonamides (except sulfachlorpyridazine).
Tetracycline (oral forms only).
Thiabendazole.
Part 1A
ANILERIDINE. | |
BUTALBITAL. | |
CODEINE, when prescribed as a single entity or when included in a preparation containing 60mg or more per dosage unit. | |
F | ETHCHLORVYNOL. |
FENTANYL and its salts. | |
HYDROCODONE (Dihydrocodeinone). | |
HYDROMORPHONE (Dihydromorphinone). | |
LEVORPHANOL. | |
MEPERIDINE (Pethidine). | |
METHAQUALONE. | |
METHYLPHENIDATE. | |
MORPHINE. | |
NORMETHADONE. | |
OXYCODONE. | |
PENTAZOCINE. | |
PROPOXYPHENE. |
Part 2
Drugs which may be sold by a pharmacist to any person after the sale is entered in the poison register and the drug is labelled as provided in section 22:
ACONITE and its alkaloids and their preparations, except external preparations containing less than 0.2% aconitine.
ALKALOIDS — all alkaloids not specifically listed elsewhere in these schedules.
ANTIMONY POTASSIUM TARTRATE (Tartar Emetic).
ARECA OIL.
ARSENIC and its preparations and compounds for veterinary use only.
BELLADONNA and its preparations and compounds, except for plasters or as provided for in Schedule B.
CHLOROFORM.
CONIUM and its preparations.
COTTONROOT and its oil, derivatives and preparations.
CROTON OIL.
ETHER.
ETHYL CHLORIDE.
FORMALDEHYDE (Formalin) and its preparations containing over 2% formaldehyde.
HYOSCYAMUS and its preparations.
LEAD SALTS and their preparations.
LOBELIA and its alkaloids and preparations, except internal preparations containing not more than 2 mg lobeline sulphate and external preparations containing not more than the equivalent of 400 mg of crude lobelia, or as provided for in Schedule B.
MERCURIAL SALTS, except Calomel and preparations containing 5% or less of Ammoniated Mercury or 2% or less of Yellow Oxide of Mercury.
NUX VOMICA and its preparations for veterinary use only.
PENNYROYAL and its oil, derivatives and preparations.
PHENOL (Carbolic Acid), except in preparations of 5% or less.
RUE and its oil, derivatives and preparations.
SANTONIN.
SAVIN and its oil, derivatives and preparations.
STRAMONIUM and its preparations.
STROPHANTHUS and its preparations.
TANSY and its oil, derivatives and preparations.
Part 3
Drugs that may be sold by a pharmacist to any person when labelled as shown below. All drugs defined in section 1, together with all new drugs other than those drugs named or included in Parts 1 and 2 of Schedule A and Schedule B. The following to be labelled "Poison" when repackaged in a pharmacy:
BARIUM SALTS, water soluble including chloride and sulphide.
BENZENE (benzol).
BORIC (Boracic) ACID and SODIUM BORATE when labelled to the effect that the drug should not be administered to infants or children under 3 years of age.
CEDAR OIL (leaf and wood).
CHENOPODIUM OIL.
CHROMIC ACID and its salts.
CREOSOTE and preparations thereof.
CRESOL (Cresylic Acid) and its preparations, and the homologues of Cresol and their preparations when stronger than 5% Cresol.
FLUORIDES for oral or topical use, but counter packages containing less than 500 mg of sodium fluoride are not required to be labelled "Poison".
GAMMA BENZENE HEXACHLORIDE.
GUAIACOL.
HELLEBORE.
HENNA.
IODINE and preparations thereof.
METHYL SALICYLATE when labelled "CAUTION — Keep out of reach of children".
NITROBENZENE when labelled as such or as NITROBENZOL or as OIL OF MIRBANE; and when the label bears the name of the pharmacy in which the sale is made and the following wording: "POISON — This chemical is POISONOUS when taken internally, inhaled or in contact with the skin. HANDLE WITH CARE and avoid skin contact and inhalation of vapours".
OXALIC ACID and its salts.
PHOSPHORUS in a free state.
PICRIC ACID (Trinitrophenol) and other nitrophenols.
PICROTOXIN.
POTASSIUM HYDROXIDE.
POTASSIUM PERMANGANATE.
SILVER NITRATE.
SODIUM HYDROXIDE.
STAVESACRE.
TETRACHLOROETHYLENE when labelled as such and where the label bears the skull and crossbones insignia and the following wording: "POISON — Vapours and odours from this solution are POISONOUS. Use only in the open air or well ventilated room"; and where the name of the pharmacy in which such sale is made is displayed on the container.
TRICHLOROETHYLENE when labelled as such and where the label bears the skull and crossbones insignia and the following wording: "POISON — Vapours and odours from this solution are POISONOUS. Use only in open air or well ventilated room"; and where the name of the pharmacy in which such sale is made is displayed on the container.
WINTERGREEN OIL when labelled "CAUTION — Keep out of the reach of children".
ZINC SALTS.
Drugs that must be stored in an area of the pharmacy to which there is no public access after July 31, 1976 and can be sold by a pharmacist to any person:
Aerosol bronchodilators.
Anticholinergics.
Drug products for parenteral use.
Drug products requiring refrigeration.
Drugs listed under "Exemptions, for Veterinary Purposes", in Schedule A, Part 1, when offered for sale for Veterinary Purposes.
Liquid Preparations Containing Camphor 6% or More, to which shall be affixed a distinctive "POISON" label in addition to the preparation's regular label.
Narcotic preparations as described in Regulation 36 to the Narcotic Control Act (Canada) and which may not be advertised or displayed to the public.
Nicotine and its salts (except in natural substances) when sold in a dosage form containing the equivalent of 2 mg or less of nicotine.
Products containing more than 1 gram of elemental iron per container, except iron derivatives for parenteral use.
Ophthalmic, otic and nasal anti-infectives.
Otic local anesthetics.
All new nonprescription drugs and
ACETYLSALICYLIC ACID, when labelled for pediatric use.
ADONIS VERNALIS.
ALCOHOLIC MEDICINALS as approved by the Liquor Control and Licensing Branch.
ANETHOLE TRITHIONE.
ANISOTROPINE METHYLBROMIDE.
ARECOLINE.
ATROPINE and its salts, when exempted in Part 1.
BETANAPHTHOL.
BUFEXAMAC.
CHLORZOXAZONE.
CHOLESTYRAMINE RESIN.
CYCRIMINE HYDROCHLORIDE.
CYPROHEPTADINE.
DEMECARIUM BROMIDE.
DESOXYRIBONUCLEASE.
DICYCLOMINE HYDROCHLORIDE.
DIMENHYDRINATE.
DIMETHOTHIAZINE MESYLATE.
DIPHENHYDRAMINE (except for topical use or in combination).
EPINEPHRINE and preparations thereof (except when sold for ophthalmic use or as an aerosol brochodilator).
EUCATROPINE.
FIBRINOLYSIN.
GLUTAMIC ACID HYDROCHLORIDE.
HIGH FAT MEAL.
HOMATROPINE and its salts.
HYDROCORTISONE or HYDROCORTISONE ACETATE, when sold as single medicinal ingredients in a concentration of 0.5% in preparations for topical use on the skin.
HYOSCINE (Scopolamine) and its salts in inhalant preparations.
IBUPROFEN and its salts, when sold as a single medicinal ingredient in a strength of 200 mg or less per dosage form.
IPECAC SYRUP.
IPECAC TINCTURE.
ISOFLUROPHATE.
ISOMETHEPTENE and its salts.
LIDOCAINE HYDROCHLORIDE 2% viscous solution.
LOPERAMIDE and its salts.
MEPHENESIN.
METHDILAZINE.
METHIONINE.
METHOCARBAMOL.
MUPIROCIN and its salts.
N-ACETYLCYSTEINE.
NIKETHAMIDE.
NITROGLYCERIN.
NYSTATIN in preparations for topical use on the skin.
ORPHENADRINE and its salts.
PABA COMPOUND for oral use.
PANCREATIN.
PEDICULOCIDES.
PENTYLENETETRAZOL.
PHENYLEPHRINE HYDROCHLORIDE for ophthalmic use, in concentrations of 2.5 per cent or less.
POTASSIUM CHLORIDE.
POTASSIUM GLUCONATE, over 100 mg per dosage unit.
PROMETHAZINE HYDROCHLORIDE (except for topical use or in combination).
PROPANTHELINE BROMIDE.
PROPYLHEXEDRINE.
QUININE and its salts, for internal use containing quinine as the single active ingredient.
SALICYLAMIDE (except as provided for in Schedule B).
SCABICIDES.
SODIUM ACID PHOSPHATE for oral use.
SODIUM CHLORIDE for ophthalmic use in concentrations greater than 0.9 per cent.
TRIMETHOBENZAMIDE.
UREA in concentrations of 40% or more.
Historical Note(s): 1974-62-Sch. A; B.C. Regs. 255/75; 596/75; 554/76; 6/77; 377/77; 274/78; 19/79; 8/80; 547/80; 416/81; 394/82; 461/87; 86/88; OIC's 1255/85; 2144/86; 2145/86; 784/87; 2157/87; 962/89; 1256/89; 1348/89; 1389/89; 1562/89; 49/91; 1553/91; 582/93; 583/93.
Part 1
The following drugs may be sold by a nonpharmacist to any person:
ACETONE.
ACHILLEA.
ACID ACETIC.
ACID BENZOIC.
ACID MURIATIC.
ACID SULPHURIC (commercial).
AGAR.
AGRIMONY.
ALCLOXA.
ALETRIS.
ALLANTOIN.
ALTHEA.
ALUMINUM ACETATE.
ALUMINUM CHLORHYDROXIDE.
ALUMINUM CHLORHYDROXIDE PROPYLENE GLYCOL COMPLEX.
ALUMINUM CHLORIDE.
ALUMINUM SULFATE.
AMMONIA.
AMMONIACUM.
AMMONIUM ACETATE.
AMMONIUM ALUMINUM SULPHATE (Alum-Ammonium Alum).
AMMONIUM BICARBONATE.
AMMONIUM CARBONATE.
AMMONIUM CHLORIDE (in cough preparations only).
AMMONIUM CITRATE (in cough preparations only).
AMMONIUM TARTRATE.
AMYL DIMETHYLAMINOBENZOATE.
ANETHOLE.
ANGELICA.
ANISE.
ARALIA RACEMOSA.
ATTAPULGITE.
BALSAM PERU.
BALSAM TOLU.
BENTONITE.
BENZALKONIUM CHLORIDE 2% or less.
BENZETHONIUM CHLORIDE.
BENZOCAINE — in preparations for topical use, 10% or less.
BENZOIN.
BENZYL ALCOHOL.
BETAINE and its salts.
BILE EXTRACT (oxbile extract).
BILE SALTS.
BLACKBERRY LEAF.
BLACK CURRANT.
BOLDO.
CALAMINE.
CALCIUM CITRATE.
CALCIUM GLYCEROPHOSPHATE.
CALCIUM HYPOPHOSPHATE.
CALCIUM LACTOPHOSPHATE.
CALCIUM OXIDE.
CALCIUM PHOSPHATE (dibasic).
CALCIUM PHOSPHATE (tribasic).
CALCIUM PHOSPHATE (monobasic).
CALCIUM POLYCARBOFIL.
CALCIUM SILICATE.
CALCIUM SUCCINATE.
CALCIUM SULFATE.
CALCIUM SULFIDE CRUDE.
CALCIUM UNDECYLENATE.
CALENDULA FLOWERS.
CALOMEL.
CALUMBA.
CAMPHOR (except in those liquid preparations containing 6% or more).
CANADA BALSAM.
CAPSAICIN.
CAPSICUM OLEORESIN.
CARBON AMORPHOUS.
CASTOR OIL.
CELANDINE.
CELERY.
CENTAURY, MINOR.
CENTRARIA ISLANDICA.
CETALKONIUM CHLORIDE.
CETRIMIDE.
CETYLPYRIDINIUM CHLORIDE.
CHALK.
CHAMOMILE FLOWERS.
CHLORAL HYDRATE, in preparations for external use, not more than 1%.
CHLORHYDROL, when in antiperspirant preparations.
CHLORIDE OF LIME.
CHLOROBUTANOL.
CHLOROTHYMOL.
CHLOROXYLENOL.
CHOLINE and its salts, except choline salicylate when sold in combination with magnesium salicylate.
CHONDRUS.
CINNAMEDRINE.
CITRIC ACID.
COCILLANA.
COD LIVER OIL.
COLTSFOOT.
COPPER (except when used in an intrauterine device).
CRESOL (Cresylic Acid) and its preparations and the homologues of Cresol and their preparations when weaker than 5% Cresol and sold in original bottles.
DIASTASE OF MALT.
DICHLOROPHENE.
DIHYDROXY-ALUMINUM AMINOACETATE.
DIHYDROXY-ALUMINUM SODIUM CARBONATE.
DIMETHICONE.
DIMETHYLPOLYSILOXANE.
DOMIPHEN BROMIDE.
EPHEDRINE in cough preparations only, 11 mg or less per dose.
EUCALYPTOL.
EUCALYPTUS.
EUGENOL.
FIBRE FROM GRAIN OR CITRUS.
FUMITORY HERB.
GENTIAN.
GINGER OLEORESIN.
GLYCERIN.
GLYCERYL GUAIACOLATE.
GLYCOL SALICYLATE.
GLYCYRRHIZA.
HEXETIDINE (in mouthwashes only).
HONEY.
HOREHOUND.
HYDROGEN PEROXIDE.
HYDROXYPROPYLMETHYCELLULOSE.
ICHTHAMMOL.
INOSITAL.
INVERT SUGAR.
IODINE SOLUTION, 3% or less.
IPECACUANHA (in cough preparations only).
ISPAGHULA.
JUNIPER BERRIES.
JUNIPER TAR.
KAOLIN.
KARAYA GUM.
LACTASE ENZYME.
LACTIC ACID (except when recommended for use by injection as a tissue sclerosing agent).
LAPPA.
LAURYLPYRIDINIUM CHLORIDE.
LECITHIN.
LEPTANDRA.
LINSEED.
LINSEED OIL.
MAGALDRATE.
MAGNESIUM HYDROXIDE.
MAGNESIUM SULFATE (Epsom salts).
MANGANESE GLYCEROPHOSPHATE.
MANGANESE HYPOPHOSPHITE.
MENTHOL.
MERBROMIN SOLUTION.
METHYLBENZETHONIUM CHLORIDE.
METHYL SALICYLATE in preparations for external use or in inhalations, 20% or less.
MYRRH.
OATS.
OIL OF ANISE.
OIL OF CAJEPUT.
OIL OF CAMPHOR.
OIL OF CINNAMON.
OIL OF CLOVE.
OIL OF EUCALYPTUS.
OIL OF HEMLOCK CANADIAN.
OIL OF LAVENDER.
OIL OF MUSTARD.
OIL OF MYRISTICA.
OIL OF PEPPERMINT.
OIL OF PINE.
OIL OF PINE NEEDLES.
OIL OF ROSEMARY.
OIL OF SASSAFRAS.
OIL OF SHARK LIVER.
OIL OF SPEARMINT.
OIL OF THYME.
OXYMETAZOLINE HC 1, in drops or nasal spray 0.05 per cent or less.
OXYQUINOLINE SULPHATE — in preparations for external use, 2% or less.
PAPAIN (except when sold or recommended as a debriding agent).
PECTIN.
PEPPERMINT.
PETROLATUM.
PETROLATUM LIQUID.
PHENOL — in preparations for external use, 2% or less.
PHENYL MERCURIC NITRATE.
PHENYLEPHRINE HYDROCHLORIDE in nose drops 0.5% or less, or in preparations for internal use, 11mg or less per dose.
PINUS SYLVESTRIS.
PIPERAZINE and its salts in dosage forms suitable for small animals.
PLANTAGO.
PLANTAGO INDICA.
PLANTAGO SEEDS HUSKS.
POPLAR BUDS.
POTASSIUM ACETATE in preparations for external use, 5% or less.
POTASSIUM ALUMINUM SULPHATE (Alum-Potash Alum).
POTASSIUM BITARTRATE (Cream of Tartar).
POTASSIUM GLUCONATE, 100 mg or less per dosage unit.
POTASSIUM NITRATE (Saltpetre).
POTASSIUM SULFATE.
PRUNE.
PSYLLIUM.
PYROXYLIN.
QUASSIA.
QUILLAJA.
RESORCINOL.
RHUBARB ROOT.
RUE.
SAFROLE.
SALICYLAMIDE, when in combination with one or more active ingredients and not exceeding 325mg per dose.
SALICYLIC ACID — in preparations for external use, 20% or less.
SALICYLIC ACID PLASTERS — 40% or less in circumscribed units of 2 cm in diameter or less.
SAMBUCUS.
SANGUINARIA.
SAPONARIA.
SELENIUM SULFIDE, when in anti-dandruff preparations, not more than 1%.
SENEGA.
SENNA.
SODIUM BICARBONATE (except in tablet form when sodium bicarbonate is the sole active ingredient).
SODIUM CAMSYLATE.
SODIUM CARBONATE.
SODIUM CARBOXYMETHYL CELLULOSE.
SODIUM CHLORIDE (except when recommended for ophthalmic use in concentrations greater than 0.9 per cent).
SODIUM CITRATE.
SODIUM FLUORIDE, when in mouthwashes, containing not more than 250mg of sodium fluoride in 500ml containers.
SODIUM PERBORATE.
SODIUM PHOSPHATE.
SODIUM POTASSIUM TARTRATE (Rochelle Salt).
SODIUM SULFIDE.
SODIUM SULPHATE (Glauber's Salts).
SOLUTION OF AMMONIA.
SQUILL (in cough preparations only).
STANNOUS FLUORIDE, when in dentifrices, not more than 0.4%.
STANNOUS OXIDE.
STRONTIUM CHLORIDE, when in dentifrices, not more than 10%.
SULFURATED POTASH.
SULPHUR.
TANNIC ACID.
TARAXACUM.
TARTARIC ACID.
TERPINEOL.
THIMEROSAL.
TITANIUM DIOXIDE.
TOLNAFTATE in preparations for external use, 1% or less.
TRICLOSAN (Irgasan DP-300).
TRIETHANOLAMINE SALICYLATE, in concentrations of not more than 20% in preparations for external use.
TRITICUM.
TURPENTINE.
UNDECYLENIC ACID — in preparations for external use, 6% or less.
UREA — in preparations for external use, 10% or less.
UVINUL N 539.
VERBASCUM.
VERBENA.
WHITE PINE.
WILD CHERRY.
WILD STRAWBERRY LEAVES, ROOT, etc.
WITCH HAZEL.
XANTHOXYLUM.
XYLOMETAZOLINE HYDROCHLORIDE in nasal drops or nasal spray 0.1% or less.
YEAST.
YELLOW DOCK.
ZINC OXIDE.
ZINC PYRIDINETHIONE, when in antidandruff preparations, not more than 2%.
ZINC PYRITHIONE.
Part 2
The following drugs may be sold by a nonpharmacist to any person, provided the drugs are
(1) contained in a product which is registered as a proprietary medicine under Division 10 of the regulations to the Food and Drugs Act (Canada); or
(2) contained in any other product when the drug's dosage does not exceed that of a product registered as in (1) above, and when the product is recommended to treat the same condition as is the proprietary medicine and when the package size of the product qualifies for registration as in (1):
ACETAMINOPHEN.
ACETYLSALICYLIC ACID (except when labelled for pediatric use).
ACID BORIC.
ALCOHOL ANHYDROUS.
ALCOHOL ISOPROPYL.
ALOE.
ALOIN.
ALUMINUM HYDROXIDE.
ALUMINUM ZIRCONYL HYDROCHLORIDE COMPLEX.
AMINOACRIDINE HCl.
ANTIPYRINE.
BELLADONNA.
BERBERINE HCl.
BISACODYL.
BISMUTH COMPOUNDS.
BLOOD ROOT.
CAFFEINE and its salts.
CALCIUM CARBONATE.
CALCIUM HYPOCHLORITE.
CALCIUM PANTOTHENATE.
CAPTAN.
CASCARA SAGRADA.
CHARCOAL ACTIVATED.
CHLOROFORM.
CHLOROPHENESIN.
CHLORPHENIRAMINE and its salts.
COLOCYNTH.
CREOSOTE.
DIOCTYL SODIUM SULFOSUCCINATE.
DIPHENYLPYRALINE HCl.
ETHYLHEXYLSALICYLATE.
FRANGULA.
GUAIACOL.
GUAIACOL CARBONATE.
HEXYLRESORCINOL.
HYDRASTINE HCl.
HYDROXYQUINOLINE.
HYOSCYAMINE and its salts, in preparations for external use, 0.125% or less.
IODINE, in concentrations of 3% or less.
JALAP.
LIVER FRACTION I.
LOBELIA.
MAGNESIUM CARBONATE.
MAGNESIUM TRISILICATE.
METHANOL.
METHYL NICOTINATE.
NAPHAZOLINE.
OIL OF CEDAR LEAF.
OIL OF TAR.
PANTOTHENYL ALCOHOL.
PEPSIN.
PEPTONE.
PHENINDAMINE TARTRATE.
PHENIRAMINE MALEATE.
PHENOLPHTHALEIN.
PHENOLPHTHALEIN YELLOW.
PHENYL SALICYLATE.
PINE TAR.
PINE TAR OIL.
POTASSIUM BICARBONATE.
POTASSIUM CHLORATE.
POTASSIUM GUAIACOL SULPHONATE.
POTASSIUM IODIDE.
PYRILAMINE MALEATE.
QUININE SULPHATE.
SENNOSIDE A & B.
SODIUM DODECYL BENZENE SULFONATE.
SODIUM SALICYLATE.
SODIUM SULFOSUCCINATE UNDECYLENIC ACID METHANOLAMIDE.
SODIUM XYLENE SULFONATE.
TERPIN HYDRATE.
TETRYZOLINE HYDROCHLORIDE.
THENYLDIAMINE HCl.
THYMOL.
UVA URSI.
ZINC CHLORIDE.
ZINC UNDECYLENATE.
Part 3
The following drugs may be sold by a nonpharmacist to any person, provided the drugs are
(1) offered for sale in original packages containing not more than 8 doses, and
(2) clearly labelled to be "For Aquarium Use Only":
ACRIFLAVINE.
ERYTHROMYCIN.
FURAZOLIDONE.
NEOMYCIN.
NITROFURAZONE.
STREPTOMYCIN.
SULPHONAMIDES.
TETRACYCLINE.
Part 4
The following drugs may be sold by a nonpharmacist to any person, provided the drugs are
(1) sold in the original, labelled container as packaged by the manufacturer, and
(2) labelled to identify the concentration of each drug and specific directions for use where the recommended daily dose does not exceed the amount shown, and
(3) not sold after a date on which the drug is indicated or labelled to expire:
Betacarotene
Vitamin A 10,000 I.U.
Vitamin B1
Vitamin B2
Niacin
Niacinamide
Pyridoxine
D-pantothenic Acid
Folic Acid 1.0 mg
Vitamin B12
Vitamin C
Vitamin D 1,000 I.U.
Vitamin E
Historical Note(s): 1974-62-Sch. B; B.C. Regs. 255/75; 596/75; 554/76; 6/77; 377/77; 274/78; 19/79; 8/80; 547/80; 416/81; 394/82; OIC's 1255/85; 2144/86; 2145/86; 2157/87; 1256/89; 1348/89; 49/91; 583/93.
Copyright (c) Queen's Printer, Victoria, British Columbia, Canada